CSS LLC’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

CSS LLC’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,600	Closed	-$400K	–	1293
2021 Q1	$400K	Buy	+10,600	New	+$264K	0.02%	630

CSS LLC's FPRX Position: Q2 2021 in Review

CSS LLC sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 46,582 shares — an estimated $1.75M sold.

CSS LLC first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $1.75M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

CSS LLC reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
CSS LLC sold 46,582 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $1.75M.
CSS LLC first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
CSS LLC's Five Prime Therapeutics, Inc. position peaked at $1.75M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.